Skip to main content
OpenTrials

Clinical trial condition

Glycogenosis 2

Explore clinical trials studying Glycogenosis 2. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Glycogenosis 2 trial results

Completed

A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease

NCT00158600

Conditions
Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Washington University Medical Center St Louis, Missouri, United States
  • Mount Sinai School of Medicine New York, United States
View Trial Details
Completed

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

NCT00074932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Colorado Health Science Center Aurora, Colorado, United States
  • Galichia Heart Hospital Wichita, Kansas, United States
  • Genzyme Medical Information Cambridge, Massachusetts, United States
  • Freeman Health Systems Joplin, Missouri, United States
View Trial Details
Completed

rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)

NCT00053573

Conditions
Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Pediatrique Hopital de Brousse Lyon, France
View Trial Details

Related conditions